Skip to main content

By Biocat

The International Society for Pharmacoepidemiology (ISPE), the International Society for Pharmacovigilance (ISoP) and the European Association for Clinical Pharmacology and Therapeutics (EACPT) have chosen Barcelona as the site for their 28th International Conference on Pharmacoepidemiology and Therapeutic Risk (ICPE 2012), which will be held from 23 to 26 August 2012.

This conference aims to create a forum where researchers, healthcare managers, professionals from the pharmaceutical industry and regulatory agencies, and other stakeholders interested in drug development and delivery, as well as in the use, costs and effects of medicines, can share opinions and expertise.

The Catalan science community, thus, has the opportunity to interact with scientists and experts from prestigious organizations in these fields, mainly from the United States, including the Food and Drug Administration (FDA), the European Medicines Agency (EMEA), the Ontario Center for Cancer Research, the Mount Sinai Lenenfeld Research Institute, the Brigham and Women’s Hospital/Harvard Medical School, the Harvard School of Public Health and the University of California, Berkeley, as well as companies like GlaxoSmithKline and Johnson&Johnson.

The opening session, on 24 August, will feature Catalan Minister of Health Boi Ruiz, 2012 Science Program Committee Chair Susana Pérez Gutthann, and ISPE President Nancy Santanello. Afterwards, Chair of the National Institute for Health and Clinical Excellence (NICE) Sir Michael Rawlins will give the keynote address entitled Perspectives on the Uses of Pharmacoepidemiology in Making Decisions About the Use of Medicines.

ICPE 2012 features an extensive program of scientific conferences, workshops and work presentations, as well as a poster and exhibit area.

Date: 23 to 26 August 2012
Venue: Barcelona International Convention Center (CCIB) • Rambla Prim, 1-17 (Forum area) • Barcelona (Spain)

Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.